HIGHLIGHTS
- who: Bernhard Mlecnik and collaborators from the Laboratory of Integrative Immunology, Paris, France Institute of Pathology, University of Bern, Bern, Switzerland have published the article: Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer, in the Journal: Cancers 2023, 15, 418. of 27/Oct/2022
- what: The authors report the Immunoscore results to stratify Stage I, Stage II, high-risk Stage II, and microsatellite-stable (MSS) CC patients, with clinical implications. The authors aimed to evaluate in these patients (n=206) the prognostic value of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.